Drugs that contain Sincalide
1. List of Kinevac drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6803046 | BRACCO | Sincalide formulations |
Aug, 2022
(5 months ago) | |
Treatment: NA
Dosage: INJECTABLE;INJECTION
2. List of Sincalide drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11318100 | MAIA PHARMS INC | Storage stable sincalide formulations |
Apr, 2038
(15 years from now) | |
| US11110063 | MAIA PHARMS INC | Storage stable sincalide formulations |
Apr, 2038
(15 years from now) | |
Market Authorisation Date: 22 November, 2022
Treatment: Accelerate the transit of a barium meal through the small bowel, thereby decreasing the time and extent of radiation associated with fluoroscopy and x-ray examination of the intestinal tract; Stimulate gallbladder contraction, as may be assessed by various methods of diagnostic imaging, or to obtain by duodenal aspiration a sample of concentrated bile for analysis; Stimulate pancreatic secretion in combination with secretin prior to obtaining a duodenal aspirate for analysis; Stimulate gallbladder contraction. as may be assessed by various methods of diagnostic imaging, or to obtain by duodenal aspiration a sample of concentrated bile for analysis; Diagnosis of gall bladder disorders or other diagnostic imaging by stimulating gallbladder contraction, as may be assessed by various methods of diagnostic imaging, or to obtain by duodenal aspiration a sample of concentrated bile for analysis; Diagnosis of pancreatic disorders by stimulating pancreatic secretion in combination with secretin prior to obtajning a duodenal aspirate for analysis; Diagnostic imaging by accelerating the tran it ofa barium meal through the small bowel, thereby decreasing the time and extent of radiation associated with fluoroscopy and x-ray examination of the intestinal tract
Dosage: POWDER;INTRAVENOUS
availability in other generic markets.
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic